Emisphere Technologies Inc. (fka EMIS)

[stocktrademan]

$EMIS recent news/filings

bullish

## source: finance.yahoo.com

Fri, 10 Apr 2015 10:02:17 GMT ~ EMISPHERE TECHNOLOGIES INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Of


read full: http://biz.yahoo.com/e/150410/emis8-k.html
*********************************************************

Tue, 07 Apr 2015 17:04:15 GMT ~ EMISPHERE TECHNOLOGIES INC Financials


read full: http://finance.yahoo.com/q/is?s=emis
*********************************************************

Tue, 31 Mar 2015 21:50:00 GMT ~ EMISPHERE TECHNOLOGIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an


read full: http://biz.yahoo.com/e/150331/emis8-k.html
*********************************************************

Tue, 31 Mar 2015 21:13:32 GMT ~ EMISPHERE TECHNOLOGIES INC Files SEC form 10-K, Annual Report


read full: http://biz.yahoo.com/e/150331/emis10-k.html
*********************************************************

Tue, 31 Mar 2015 12:30:00 GMT ~ Emisphere Technologies Inc Earnings Call scheduled for 8:30 am ET today


read full: http://biz.yahoo.com/cc/9/148939.html
*********************************************************

$EMIS charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$EMIS company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/EMIS/company-info
Ticker: $EMIS
OTC Market Place: OTCQB
CIK code: 0000805326
Company name: Emisphere Technologies, Inc.
Company website: http://www.emisphere.com
Incorporated In: DE, USA

Business Description: Emisphere Technologies, Inc. is specialty pharmaceutical company preparing to commence commercial operations. The Company is currently preparing to launch its first prescription product, oral Eligen B12, in the U.S. Beyond Eligen B12, the Company utilizes its proprietary Eligen Technology to create new oral formulations of therapeutic agents. Emisphere is currently partnered with global pharmaceutical companies for the development of new orally delivered therapeutics. For more information, please visit www.emisphere.com.Less >>

$EMIS share structure

## source: otcmarkets.com

Market Value: $40,053,735 a/o Apr 10, 2015
Shares Outstanding: l PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">; OTC Markets | Official site of the OTCQX, OTCQB and OTC Pink Marketplaces featuring Free Stock & Bond Quotes, Trade Prices, Chart, Financials and Company News & Information for Investors, Companies and Traders - OTCMarkets.com var appSection = "otcqb" ; var tierGroupId = "DQ"; var symbol = "EMIS"; var jq191 = $.noConflict(true); var appNav = new OTCMarketsAppNav(); var iqCaller = new OtcIQCalls(); var commonCaller = new PinkCommonCalls(); var contentCaller = new PinkContentCalls(); var edgarCaller = new PinkEdgarCalls(); var decorateSymbols = new SymbolDecorator(commonCaller); height="0" width="0" style="display:none;visibility:hidden"> (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= '//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer',"GTM-N65JXN"); OTC Markets Home Marketplaces Market Activity Current Market Closing Summary Broker Dealer Data Corporate Actions Short Sale Data Reg SHO Data News Company News & Financials Press Releases Videos & Presentations RSS Feeds OTC Markets Events OTC Markets Newsletter OTC Markets Press Center Services Companies Investors Market Data Trading Research Stock Screener OTCQX Company List Company Directory Service Provider Directory OTCQX Advisor List Broker Dealer Directory Prohibited Attorney List Symbology Glossary Learn Our Marketplaces Market 101 Investor Protection Reporting Requirements American Depositary Receipts (ADRs) Apply for OTCQX - Our Best Marketplace Comply with New OTCQB Requirements Information for OTC Pink Companies How to Get Traded Caveat Emptor Policy FINRA & SEC Rules Whitepapers FAQs tierTitle = getTierTitle("otcqb"); Company Directory | Stock Screener OTC Market Totals - Securities - Dollar Volume - Share Volume - Trades var glossaryDecorator = new GlossaryDecorator (contentCaller) ; $('p').each (function () { var glossaryId = $(this).attr('glossaryId'); if (glossaryId) this.psGlossaryId=glossaryId; }); if (document.getElementById('p')) glossaryDecorator .doSection (document.getElementById ('p')); $('#quoteEntry input#quoteBox').focus(function() { toggleFieldValue(this, 'Enter Symbol/Company Name', ''); }).blur(function() { toggleFieldValue(this, '', 'Enter Symbol/Company Name'); }); var security = new SecurityInfo(10692, 25861, "Emisphere Technologies, Inc.", "EMISPHERE TECH INC", "EMIS", "OTC Link", true, true, undefined, "Common Stock", 10, "OTCQB", false, false, true, false, 0.010000000000000, "0.01", undefined, false, 1.0, undefined); var symbolSecurity = (security.symbol)? security.symbol:security.secId; var initNewsId = undefined; var glossaryDecorator = new GlossaryDecorator (contentCaller) ; Quote Charts Company Profile News Financials Filings and Disclosure Short Sales Insider Disclosure Research Reports Videos and Presentations EMIS Emisphere Technologies, Inc. Common Stock SEC Reporting - Current OTCQB function doOTCQX30Logo(url) { var CONSTITUENTS_DATA; if ($.browser.msie) { var http = new XDomainRequest(); http.open("get", url); http.onload = function() { var data = http.responseText; if (typeof data === "undefined") return; CONSTITUENTS_DATA = JSON.parse(data); displayIndexLogo(CONSTITUENTS_DATA); }; http.send(null); } else { $.ajax({ type : "GET", url : url, data : {}, success : function(data) { if (typeof data === "undefined") return; CONSTITUENTS_DATA = JSON.parse(data); displayIndexLogo(CONSTITUENTS_DATA); } }); } } function displayIndexLogo(constituents) { if (typeof constituents === undefined) { if (console && console.log) { console.log("Unable to load constituents."); } } var result = $.grep(constituents, function(e){ return e.ticker == security.symbol; }); if (result.length > 0) { $('.tierLogoContainer a').attr('href', '/index/.OTCQX30/quote'); $('.tierLogo').attr('src', '/content/doc/otcm/tier/logo/small/otcqx30.png'); $('.tierLogo').attr('alt','OTCM QX ADR 30 Index Constituent'); $('.tierLogo')[0].psGlossaryId='otcqx30-constituent'; handler.decorateGlossary(); } } var json_url = "http://s3.amazonaws.com/content.otcmarkets.com/constituents/otcqx_30_list.json";; doOTCQX30Logo(json_url); var handler = new QuoteHandler(); handler.checkCaveat(); var tradeHeaderHandler; if (!window.location.href.match('quote')) tradeHeaderHandler = new TradeHeaderHandler(iqCaller, window.document.getElementById('quoteBar')); if (security.symbol == null || security.symbol.length == 0) { $('#quoteUnderArrowTabs li.eqOnly').hide(); } $('img').each(function () { var glossaryId = $(this).attr('glossaryId'); if (glossaryId) this.psGlossaryId = glossaryId; }); handler.decorateGlossary(); $("#title").html('Company Info'); var shortDesc = "Emisphere Technologies, Inc. is specialty pharmaceutical company preparing to commence commercial operations. The Company is currently preparing to launch its first prescription product, oral Eligen B12, in the U.S. Beyond Eligen B12, the Company utilizes its proprietary Eligen Technology to create new oral formulations of therapeutic agents. Emisphere is currently partnered with global pharmaceutical companies for the development of new orally delivered therapeutics. For more information, plea...More >>"; var longDesc = "Emisphere Technologies, Inc. is specialty pharmaceutical company preparing to commence commercial operations. The Company is currently preparing to launch its first prescription product, oral Eligen B12, in the U.S. Beyond Eligen B12, the Company utilizes its proprietary Eligen Technology to create new oral formulations of therapeutic agents. Emisphere is currently partnered with global pharmaceutical companies for the development of new orally delivered therapeutics. For more information, please visit www.emisphere.com.Less >>"; function toggleFullDescription(full) { if (full) { $("#businessContent p").html(longDesc); }else { $("#businessContent p").html(shortDesc); } } Company Updated Profile Contact Info 4 Becker Farm Road Suite 103 Roseland, NJ 07068 Website: http://www.emisphere.com Phone: [phone] Business Description toggleFullDescription(false); Financial Reporting/Disclosure Reporting Status U.S. Reporting: SEC Filer
Float: 46,144,726 a/o Feb 13, 2015
Authorized Shares: 400,000,000 a/o Feb 13, 2015
Par Value: 0.01

$EMIS extra dd links

Company name: Emisphere Technologies, Inc.
Company website: http://www.emisphere.com

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/EMIS/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/EMIS/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=EMIS+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=EMIS+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=EMIS+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/EMIS/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/EMIS/news - http://finance.yahoo.com/q/h?s=EMIS+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/EMIS/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/EMIS/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/EMIS/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/EMIS/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/EMIS/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/EMIS/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/EMIS/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/EMIS/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=EMIS+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/EMIS
DTCC (dtcc.com): http://search2.dtcc.com/?q=Emisphere+Technologies%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Emisphere+Technologies%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Emisphere+Technologies%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.emisphere.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.emisphere.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.emisphere.com

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/EMIS/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/EMIS
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/EMIS/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/EMIS/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/EMIS/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000805326&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/EMIS/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/EMIS/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/EMIS/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/EMIS/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=EMIS&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=EMIS
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/EMIS/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=EMIS+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=EMIS+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=EMIS
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=EMIS
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=EMIS+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/EMIS/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=EMIS+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/EMIS.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=EMIS
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/EMIS/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/EMIS/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/EMIS/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/EMIS/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/EMIS
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/EMIS
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/EMIS:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=EMIS
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=EMIS



$EMIS DD Notes ~ http://www.ddnotesmaker.com/EMIS